Roswell Park Cancer Institute has been named a 2017–18 Best Hospital for cancer by U.S. News & World Report. The Buffalo, N.Y., comprehensive cancer center was ranked by the news outlet as 33rd among nearly 900 cancer hospitals reviewed nationwide, and was also recognized as high-performing within two other categories: urology and lung cancer surgery.

The U.S. Food and Drug Administration has awarded orphan drug status to a promising immunotherapy vaccine developed at Roswell Park Comprehensive Cancer Center. The FDA notified MimiVax LLC, a Roswell Park spinoff company, on Aug. 3 that its application for orphan status for SurVaxM as treatment for glioblastoma, a type of brain cancer, had been approved.

Today, 101 cyclists crossed the Niagara Falls finish line to complete the Empire State Ride (ESR), a seven-day, 546-mile adventure across New York State to end cancer. To participate, individuals from as far as California and the Virgin Islands raised more than $500,000 to support cancer research at Roswell Park Comprehensive Cancer Center.

Lee Hales, BS, CMD, Chief Medical Dosimetrist in the Department of Radiation Medicine at Roswell Park Comprehensive Cancer Center, has been named to a one-year term as President-Elect of the American Association of Medical Dosimetrists (AAMD), an international professional organization with approximately 4,000 members. He expects to serve the organization as a leader for three years, including successive terms as president and past president.

Two comprehensive cancer centers are uniting to bring researchers and the diverse community of indigenous North American populations together for an unprecedented exchange of ideas, information and cultural enrichment.